中東・北アフリカの動物用医薬品市場:動物別{畜産動物(ウマ、ウシ&ラクダ、ウシ、カプリン)、家禽類(ブリーダー、ブロイラー)、ペット(イヌ、ネコ)}、製品別{抗菌剤(水溶性粉末、経口剤、飼料プレミックス、注射剤、その他)、駆虫薬(経口粉末、経口懸濁液、注射剤、その他)、抗コクシジウム剤(経口液、飼料プレミックス、その他)、抗炎症剤、代謝促進剤、栄養補助食品}, 国別, 競争, 予測 & 機会, 2018-2028FMiddle East & North Africa Veterinary Pharmaceuticals Market By Animal {Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine), Poultry (Breeders, Broilers), Pets (Canine, Feline)}, By Product {Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others), Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others), Anticoccidials (Oral Solutions, Feed Premixes, Others), Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements}, Country, Competition, Forecast & Opportunities, 2018-2028F 中東・北アフリカの動物用医薬品市場は今後数年間、目覚しいCAGRで成長する。ペットに対する愛情の高まりと、動物の健康に対する一般市民の知識の増加は、いずれも中東・北アフリカの動物用医薬品市場の成長に貢... もっと見る
サマリー中東・北アフリカの動物用医薬品市場は今後数年間、目覚しいCAGRで成長する。ペットに対する愛情の高まりと、動物の健康に対する一般市民の知識の増加は、いずれも中東・北アフリカの動物用医薬品市場の成長に貢献する。さらに、感染性疾患の増加が今後数年間の市場拡大を促進すると予想される。さらに、家畜生産の拡大、食肉消費の増加、人獣共通感染症の発生率の増加が、中東・北アフリカの動物用医薬品市場の今後の成長を促進しています。 今後数年間、中東・北アフリカの動物用医薬品市場は、動物サービスに関連する高コスト、インフラの不足、動物実験に関連するコストの上昇、抗生物質の使用をめぐる厳しい規制などの課題に直面する可能性がある。 動物の感染症ケースの増加 家畜の健康に対する主な脅威は、リケッチア、ウイルス、細菌、真菌による感染症である。いくつかの原虫病は感染症と似た症状を示し、頻繁に分類される。細菌、ウイルス、寄生虫などの病原性(病気を引き起こす)微生物に汚染された食物や水を摂取することが、感染症の主な原因である。体内に侵入した後、通常、消化管で症状を引き起こし始める。汚染は農場から食卓までのフードチェーン全体で起こりうるものであり、管理と予防が必要である。動物の病気は、細菌、ウイルス、寄生虫、真菌、栄養不良、化学毒などによって引き起こされる。中東・北アフリカ市場は、動物における感染症の発生が増加しているため、今後数年でさらに急成長すると予想される。 ペット飼育の増加 食料とシェルターを必要とする動物を支援するため、多くの人々が犬を飼うようになっている。ペット救済団体や動物保護施設は、満足し、健康な動物が家を待っている状態で溢れている。パピーミルに対抗する戦略のひとつに、ペットの養子縁組がある。ペットショップ、オンライン業者、フリーマーケットから動物を購入する飼い主は、さらに、パピーミルから犬を購入していることになる。パピーミルとして知られる工場式の繁殖事業は、イヌの幸福よりも金銭的利益を優先する。パピーミルと呼ばれる工場式繁殖は、イヌの幸福よりも金銭的利益を優先させる。パピーミルの動物たちは、医療措置が不十分な劣悪な環境で飼育され、その結果、深刻な病気や問題行動を起こすことが多い。中東・北アフリカの動物用医薬品市場の今後数年間の成長は、ペット飼育に対する懸念の高まりと動物医療に対する意識の高まりに支えられている。 市場区分 中東・北アフリカの動物用医薬品市場は、動物別と製品別に区分することができる。動物セグメントに基づくと、市場はさらに畜産動物、家禽、ペットに分けられる。畜産動物に基づくと、市場はウマ、ウシ&ラクダ、ヒツジ、ウシに細分化される。家禽に基づくと、市場はブリーダーとブロイラーに細分化される。ペットに基づくと、市場はイヌとネコに細分化される。製品別では、抗菌剤、駆虫剤、抗コクシジウム剤、抗炎症剤、代謝促進剤、栄養補助食品に分けられる。抗菌剤に基づくと、市場はさらに水溶性粉末、経口溶液、飼料プレミックス、注射剤、その他に細分化される。駆虫薬に基づくと、市場はさらに経口粉末、経口懸濁液、注射剤、その他に細分化される。抗コクシジウム剤に基づくと、市場はさらに経口溶液、飼料プレミックス、その他に細分化される。 市場プレイヤー United Company For Veterinary Medicines Industry (UNIVET)、MSD Animal Health、Al Mutawwaj Veterinary Pharmaceutical Industries、Boehringer Ingelheim Ltd.、VAPCO Manufacturing CO.Ltd.、AlQuds Pharmaceutical Group、Megavet Veterinary Medicine LLC、The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco)、Saudi Pharmaceutical Industries、Virbac Groupなどが中東・北アフリカ動物用医薬品市場で事業を展開する大手企業です。 レポートの範囲 本レポートでは、中東・北アフリカの動物用医薬品市場を、業界動向に加えて以下のカテゴリーに分類しています: - 中東・北アフリカの動物用医薬品市場:動物別 o 畜産動物(ウマ、ウシ&ラクダ、ウシ、カプリン) o 家禽(ブリーダー、ブロイラー) o ペット(イヌ、ネコ) - 中東・北アフリカの動物用医薬品市場:製品別 o 抗菌剤(水溶性粉末、経口剤、飼料プレミックス、注射剤、その他) o 駆虫薬(経口粉末、経口懸濁液、注射剤、その他) o 抗コクシジウム剤(経口剤、飼料プレミックス、その他) o 抗炎症剤 o 代謝促進剤 o 栄養補助食品 競合状況 企業プロフィール:中東・北アフリカの動物用医薬品市場に参入している主要企業の詳細分析 利用可能なカスタマイズ: TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供します。このレポートでは以下のカスタマイズが可能です: 企業情報 - 追加市場参入企業(最大5社)の詳細分析とプロファイリング 目次1. Product Overview1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Impact of COVID-19 on Middle East & North Africa Pharmaceuticals Market 5. Middle East & North Africa Pharmaceuticals Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.2.1.2. By Poultry (Breeders, Broilers) 5.2.1.3. By Pets (Canine, Feline) 5.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.2.3. By Country 5.2.4. By Company (2022) 5.3. Market Map 5.3.1. By Animal 5.3.2. By Product 5.3.3. By Country 5.4. Middle East & North Africa: Country Analysis 5.4.1. Saudi Arabia Veterinary Pharmaceuticals Market Outlook 5.4.1.1. Market Size & Forecast 5.4.1.1.1. By Value 5.4.1.2. Market Share & Forecast 5.4.1.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.1.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.1.2.1.2. By Poultry (Breeders, Broilers) 5.4.1.2.1.3. By Pets (Canine, Feline) 5.4.1.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.1.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.1.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.1.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.2. UAE Veterinary Pharmaceuticals Market Outlook 5.4.2.1. Market Size & Forecast 5.4.2.1.1. By Value 5.4.2.2. Market Share & Forecast 5.4.2.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.2.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.2.2.1.2. By Poultry (Breeders, Broilers) 5.4.2.2.1.3. By Pets (Canine, Feline) 5.4.2.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.2.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.2.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.2.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.3. Kuwait Veterinary Pharmaceuticals Market Outlook 5.4.3.1. Market Size & Forecast 5.4.3.1.1. By Value 5.4.3.2. Market Share & Forecast 5.4.3.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.3.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.3.2.1.2. By Poultry (Breeders, Broilers) 5.4.3.2.1.3. By Pets (Canine, Feline) 5.4.3.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.3.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.3.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.3.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.4. Qatar Veterinary Pharmaceuticals Market Outlook 5.4.4.1. Market Size & Forecast 5.4.4.1.1. By Value 5.4.4.2. Market Share & Forecast 5.4.4.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.4.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.4.2.1.2. By Poultry (Breeders, Broilers) 5.4.4.2.1.3. By Pets (Canine, Feline) 5.4.4.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.4.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.4.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.4.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.5. Oman Veterinary Pharmaceuticals Market Outlook 5.4.5.1. Market Size & Forecast 5.4.5.1.1. By Value 5.4.5.2. Market Share & Forecast 5.4.5.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.5.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.5.2.1.2. By Poultry (Breeders, Broilers) 5.4.5.2.1.3. By Pets (Canine, Feline) 5.4.5.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.5.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.5.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.5.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.6. Bahrain Veterinary Pharmaceuticals Market Outlook 5.4.6.1. Market Size & Forecast 5.4.6.1.1. By Value 5.4.6.2. Market Share & Forecast 5.4.6.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.6.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.6.2.1.2. By Poultry (Breeders, Broilers) 5.4.6.2.1.3. By Pets (Canine, Feline) 5.4.6.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.6.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.6.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.6.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.7. Egypt Veterinary Pharmaceuticals Market Outlook 5.4.7.1. Market Size & Forecast 5.4.7.1.1. By Value 5.4.7.2. Market Share & Forecast 5.4.7.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.7.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.7.2.1.2. By Poultry (Breeders, Broilers) 5.4.7.2.1.3. By Pets (Canine, Feline) 5.4.7.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.7.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.7.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.7.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.8. Algeria Veterinary Pharmaceuticals Market Outlook 5.4.8.1. Market Size & Forecast 5.4.8.1.1. By Value 5.4.8.2. Market Share & Forecast 5.4.8.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.8.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.8.2.1.2. By Poultry (Breeders, Broilers) 5.4.8.2.1.3. By Pets (Canine, Feline) 5.4.8.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.8.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.8.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.8.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.9. Morocco Veterinary Pharmaceuticals Market Outlook 5.4.9.1. Market Size & Forecast 5.4.9.1.1. By Value 5.4.9.2. Market Share & Forecast 5.4.9.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.9.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.9.2.1.2. By Poultry (Breeders, Broilers) 5.4.9.2.1.3. By Pets (Canine, Feline) 5.4.9.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.9.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.9.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.9.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.10. Tunisia Veterinary Pharmaceuticals Market Outlook 5.4.10.1. Market Size & Forecast 5.4.10.1.1. By Value 5.4.10.2. Market Share & Forecast 5.4.10.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.10.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.10.2.1.2. By Poultry (Breeders, Broilers) 5.4.10.2.1.3. By Pets (Canine, Feline) 5.4.10.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.10.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.10.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.10.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 6. Market Dynamics 6.1. Drivers 6.2. Challenges 7. Market Trends & Developments 7.1. Recent Developments 7.2. Mergers & Acquisitions 7.3. Product Launches 8. Porter’s Five Forces Analysis 8.1. Competition in the Industry 8.2. Potential of New Entrants 8.3. Power of Suppliers 8.4. Power of Customers 8.5. Threat of Substitute Products 9. Competitive Landscape 9.1. Business Overview 9.2. Product Offerings 9.3. Recent Developments 9.4. Financials (As Reported) 9.5. Key Personnel 9.6. SWOT Analysis 9.6.1. United Company For Veterinary Medicines Industry (UNIVET) 9.6.2. MSD Animal Health 9.6.3. Al Mutawwaj Veterinary Pharmaceutical Industries 9.6.4. Boehringer Ingelheim Ltd. 9.6.5. VAPCO Manufacturing CO. Ltd. 9.6.6. AlQuds Pharmaceutical Group 9.6.7. Megavet Veterinary Medicine LLC 9.6.8. The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco) 9.6.9. Saudi Pharmaceutical Industries 9.6.10. Virbac Group 10. Strategic Recommendations
SummaryMiddle East & North Africa Veterinary Pharmaceuticals Market will grow in the coming years with an impressive CAGR. The growing affection for pets and increased public knowledge of animal health will both contribute to the growth of the Middle East and North Africa Veterinary Pharmaceuticals market. Additionally, an increase in infectious disorders is expected to promote market expansion in the upcoming years. Table of Contents1. Product Overview1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Impact of COVID-19 on Middle East & North Africa Pharmaceuticals Market 5. Middle East & North Africa Pharmaceuticals Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.2.1.2. By Poultry (Breeders, Broilers) 5.2.1.3. By Pets (Canine, Feline) 5.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.2.3. By Country 5.2.4. By Company (2022) 5.3. Market Map 5.3.1. By Animal 5.3.2. By Product 5.3.3. By Country 5.4. Middle East & North Africa: Country Analysis 5.4.1. Saudi Arabia Veterinary Pharmaceuticals Market Outlook 5.4.1.1. Market Size & Forecast 5.4.1.1.1. By Value 5.4.1.2. Market Share & Forecast 5.4.1.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.1.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.1.2.1.2. By Poultry (Breeders, Broilers) 5.4.1.2.1.3. By Pets (Canine, Feline) 5.4.1.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.1.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.1.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.1.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.2. UAE Veterinary Pharmaceuticals Market Outlook 5.4.2.1. Market Size & Forecast 5.4.2.1.1. By Value 5.4.2.2. Market Share & Forecast 5.4.2.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.2.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.2.2.1.2. By Poultry (Breeders, Broilers) 5.4.2.2.1.3. By Pets (Canine, Feline) 5.4.2.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.2.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.2.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.2.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.3. Kuwait Veterinary Pharmaceuticals Market Outlook 5.4.3.1. Market Size & Forecast 5.4.3.1.1. By Value 5.4.3.2. Market Share & Forecast 5.4.3.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.3.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.3.2.1.2. By Poultry (Breeders, Broilers) 5.4.3.2.1.3. By Pets (Canine, Feline) 5.4.3.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.3.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.3.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.3.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.4. Qatar Veterinary Pharmaceuticals Market Outlook 5.4.4.1. Market Size & Forecast 5.4.4.1.1. By Value 5.4.4.2. Market Share & Forecast 5.4.4.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.4.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.4.2.1.2. By Poultry (Breeders, Broilers) 5.4.4.2.1.3. By Pets (Canine, Feline) 5.4.4.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.4.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.4.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.4.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.5. Oman Veterinary Pharmaceuticals Market Outlook 5.4.5.1. Market Size & Forecast 5.4.5.1.1. By Value 5.4.5.2. Market Share & Forecast 5.4.5.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.5.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.5.2.1.2. By Poultry (Breeders, Broilers) 5.4.5.2.1.3. By Pets (Canine, Feline) 5.4.5.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.5.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.5.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.5.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.6. Bahrain Veterinary Pharmaceuticals Market Outlook 5.4.6.1. Market Size & Forecast 5.4.6.1.1. By Value 5.4.6.2. Market Share & Forecast 5.4.6.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.6.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.6.2.1.2. By Poultry (Breeders, Broilers) 5.4.6.2.1.3. By Pets (Canine, Feline) 5.4.6.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.6.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.6.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.6.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.7. Egypt Veterinary Pharmaceuticals Market Outlook 5.4.7.1. Market Size & Forecast 5.4.7.1.1. By Value 5.4.7.2. Market Share & Forecast 5.4.7.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.7.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.7.2.1.2. By Poultry (Breeders, Broilers) 5.4.7.2.1.3. By Pets (Canine, Feline) 5.4.7.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.7.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.7.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.7.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.8. Algeria Veterinary Pharmaceuticals Market Outlook 5.4.8.1. Market Size & Forecast 5.4.8.1.1. By Value 5.4.8.2. Market Share & Forecast 5.4.8.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.8.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.8.2.1.2. By Poultry (Breeders, Broilers) 5.4.8.2.1.3. By Pets (Canine, Feline) 5.4.8.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.8.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.8.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.8.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.9. Morocco Veterinary Pharmaceuticals Market Outlook 5.4.9.1. Market Size & Forecast 5.4.9.1.1. By Value 5.4.9.2. Market Share & Forecast 5.4.9.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.9.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.9.2.1.2. By Poultry (Breeders, Broilers) 5.4.9.2.1.3. By Pets (Canine, Feline) 5.4.9.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.9.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.9.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.9.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 5.4.10. Tunisia Veterinary Pharmaceuticals Market Outlook 5.4.10.1. Market Size & Forecast 5.4.10.1.1. By Value 5.4.10.2. Market Share & Forecast 5.4.10.2.1. By Animal (Livestock Animals, Poultry, Pets) 5.4.10.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine) 5.4.10.2.1.2. By Poultry (Breeders, Broilers) 5.4.10.2.1.3. By Pets (Canine, Feline) 5.4.10.2.2. By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements) 5.4.10.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others) 5.4.10.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others) 5.4.10.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others) 6. Market Dynamics 6.1. Drivers 6.2. Challenges 7. Market Trends & Developments 7.1. Recent Developments 7.2. Mergers & Acquisitions 7.3. Product Launches 8. Porter’s Five Forces Analysis 8.1. Competition in the Industry 8.2. Potential of New Entrants 8.3. Power of Suppliers 8.4. Power of Customers 8.5. Threat of Substitute Products 9. Competitive Landscape 9.1. Business Overview 9.2. Product Offerings 9.3. Recent Developments 9.4. Financials (As Reported) 9.5. Key Personnel 9.6. SWOT Analysis 9.6.1. United Company For Veterinary Medicines Industry (UNIVET) 9.6.2. MSD Animal Health 9.6.3. Al Mutawwaj Veterinary Pharmaceutical Industries 9.6.4. Boehringer Ingelheim Ltd. 9.6.5. VAPCO Manufacturing CO. Ltd. 9.6.6. AlQuds Pharmaceutical Group 9.6.7. Megavet Veterinary Medicine LLC 9.6.8. The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco) 9.6.9. Saudi Pharmaceutical Industries 9.6.10. Virbac Group 10. Strategic Recommendations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechSci Research社の世界/地域別市場調査分野での最新刊レポート
本レポートと同じKEY WORD(veterinary)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|